Sarepta Therapeutics Inc (SRPT)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 1,103,010 | 197,855 | 383,622 | 427,290 | 428,430 | 541,932 | 851,929 | 871,668 | 966,777 | 1,038,620 | 868,565 | 1,233,880 | 2,115,870 | 1,599,110 | 1,697,280 | 1,481,840 | 1,502,650 | 1,474,640 | 1,639,960 | 1,764,210 |
| Short-term investments | US$ in thousands | 251,782 | 1,000,530 | 1,076,850 | 963,453 | 1,247,820 | 1,191,610 | 1,008,790 | 1,010,430 | 1,022,600 | 1,033,860 | 1,059,450 | 779,548 | 0 | 0 | 30,000 | 255,997 | 435,923 | 341,467 | 421,349 | 406,940 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 731,684 | 699,489 | 688,490 | 608,709 | 653,659 | 450,743 | 498,654 | 536,884 | 619,604 | 602,916 | 545,566 | 454,962 | 452,733 | 373,443 | 425,022 | 364,736 | 416,026 | 378,388 | 354,896 | 306,429 |
| Quick ratio | 1.85 | 1.71 | 2.12 | 2.28 | 2.56 | 3.85 | 3.73 | 3.51 | 3.21 | 3.44 | 3.53 | 4.43 | 4.67 | 4.28 | 4.06 | 4.76 | 4.66 | 4.80 | 5.81 | 7.09 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,103,010K
+ $251,782K
+ $—K)
÷ $731,684K
= 1.85
The quick ratio of Sarepta Therapeutics Inc has shown a gradual decline over the observed periods, indicating a potential decrease in the company's ability to cover its short-term liabilities with its most liquid assets. As of December 31, 2024, the quick ratio was 1.85, suggesting that the company had $1.85 of liquid assets to cover $1 of current liabilities. This ratio has decreased from a high of 7.09 on March 31, 2020. A quick ratio below 1 indicates that the company may struggle to meet its short-term obligations without having to rely on selling inventory or obtaining additional financing. It is essential for stakeholders to monitor this trend closely to assess the company's liquidity position and financial health.
Peer comparison
Dec 31, 2024